ClinicalTrials.Veeva

Menu

The Bupivacaine Dose Sparing Effect of Intrathecal Epinephrine

S

Seoul Medical Center

Status

Completed

Conditions

Spinal Anesthesia

Treatments

Drug: Epi 200
Drug: epinephrine 25
Drug: Placebo
Drug: Epinephrine 50
Drug: epinephrine 100

Study type

Interventional

Funder types

Other

Identifiers

NCT01261078
SMC-2010-12-05

Details and patient eligibility

About

Intrathecal epinephrine has been known to increase the duration of spinal anesthesia, or increase the quality of anesthesia. However, there is still a controversy, and the mechanism of epinephrine is recently suggested as a modulator of pain information in the spinal cord. Therefore, the investigators try to investigate the dose sparing effect of intrathecal epinephrine for spinal anesthesia with bupivacaine.

Full description

For patient undergoing total knee replacement arthroplasty, patients injected intrathecally with bupivacaine 8 mg were compared with those with bupivacaine 8 mg with 25 mcg of epinephrine, bupivacaine 8 mg with 50 mcg of epinephrine, and those with bupivacaine 8 mg with 100 mcg of epinephrine. The investigators compared the characteristics of spinal anesthesia including the quality and complication of spinal anesthesia. The researchers investigated whether intrathecal dose of epinephrine can reduce bupivacaine requirement and this effect is dependent on the dose of epinephrine.

Enrollment

75 estimated patients

Sex

All

Ages

40 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient undergoing total knee replacement arthroplasty

Exclusion criteria

  • patient with cardiac or pulmonary disease (ASA class III or more)
  • patient undergone previous spine surgery
  • patient undergoing revised knee replacement

Trial design

75 participants in 5 patient groups, including a placebo group

Placebo
Placebo Comparator group
Description:
8 mg bupivacaine only
Treatment:
Drug: Placebo
Epi 25
Active Comparator group
Description:
8 mg of bupivacaine mixed with 25 mcg of epinephrine
Treatment:
Drug: epinephrine 25
Epi 50
Active Comparator group
Description:
8 mg of bupivacaine mixed with 50 mcg of epinephrine
Treatment:
Drug: Epinephrine 50
Epi 100
Active Comparator group
Description:
8 mg of bupivacaine mixed with 0.1 mg of epinephrine
Treatment:
Drug: epinephrine 100
Epi 200
Active Comparator group
Description:
intrathecal bupivacaine 8 mg with 200 mcg of epinephrine
Treatment:
Drug: Epi 200

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems